This systematic review and meta-analysis clarifies the major and minor risk factors associated with developing early-onset food allergy to inform optimal prevention clinical practice, policy, and ...

The key urban design interventions that can demonstrate measurable improvements in health and wellbeing outcomes ...

Animal studies often fail to predict human tissue responses to new drugs or newly developed therapies. Besides generating tremendous costs for clinical studies, it also raises significant ethical ...

Columbia University’s School of Professional Studies (SPS) is excited to introduce a redesigned curriculum for its Master of Science in Human Capital Management (HCM) program, aligning the program ...

In a member webinar hosted by techUK, experts from the Medicines and Healthcare products Regulatory Agency (MHRA) provided a comprehensive introduction to the UK’s regulatory framework for software as ...

TERI School of Advanced Studies (TERI SAS | Deemed to be University, Vasant Kunj, New Delhi), the academic institution of The Energy and Resources Institute (TERI), celebrated its 18th Convocation ...

CHICAGO, IL - March 19, 2026 - PRESSADVANTAGE - Universal Wellness Roscoe Village has spotlighted the personal journey ...

Quality evidence is needed to support a new Medicare Part D medication therapy management (MTM) program performance measure, prompting a scoping review on MTM services and associated outcomes.

He stated, "I have made the decision to retire as CEO of electroCore effective April 1, 2026... With that foundation now in place, the board and I believe this is the right time to begin a leadership ...

HONG KONG SAR - Media OutReach Newswire - 10 March 2026 - AECOM, the trusted global infrastructure leader, supported the release of the Hong Kong Nature-based Solutions Design Guidelines (HKNbSDG), a ...

You can access top-quality education from Scotland’s University of the Year, from the comfort of your own home.

In a call hosted recently, Nasus Pharma (NYSE:NSRX) presented strong positive topline results from its Phase 2 clinical study ...